Anavex Life Sciences Corp. (AVXL) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 6.78M | 10.84M | 14.46M | 12.51M | 13.59M | 14.34M | 14.6M | 12.62M | 11.38M | 12.65M | 13.53M | 14.19M | 15.36M | 15.28M | 12.46M | 11.52M | 11.72M | 12.25M | 11.36M | 8.94M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 2.13M | 3.55M | 4.5M | 2.62M | 3.15M | 2.78M | 2.79M | 2.9M | 2.69M | 2.59M | 3.25M | 2.88M | 3.32M | 3.9M | 3.19M | 2.92M | 3.07M | 2.88M | 2.43M | 2.23M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 4.66M | 7.29M | 9.96M | 9.89M | 10.45M | 11.55M | 11.81M | 9.73M | 8.68M | 10.06M | 10.28M | 10.56M | 12.07M | 11.38M | 9.27M | 8.6M | 8.66M | 9.37M | 8.96M | 6.72M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 750K | -25K | 0 | 0 | 0 | 0 | 0 | -43.28K | -10.82K |
| Operating Income | -6.78M | -10.84M | -14.46M | -12.51M | -13.59M | -14.34M | -14.6M | -12.62M | -11.38M | -12.65M | -13.53M | -14.19M | -15.36M | -15.28M | -12.46M | -11.52M | -11.72M | -12.25M | -11.36M | -8.94M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 50.1% | 24.36% | 0.99% | 0.88% | -19.46% | -13.31% | -7.92% | 11.04% | 25.92% | 17.22% | -8.61% | -23.18% | -31.01% | -24.75% | -9.72% | -28.8% | -24.77% | -63.19% | -40.08% | -16.18% |
| EBITDA | -5.66M | -6.49M | -14.31M | -12.42M | -13.58M | -11.74M | -14.08M | -12.15M | -8.62M | -10.21M | -11.24M | -12.09M | -12.99M | -14.08M | -12.28M | -10.41M | -10.85M | -11.58M | -10.14M | -8.94M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 58.3% | 44.78% | -1.63% | -2.18% | -57.5% | -15.02% | -25.25% | -0.49% | 33.64% | 27.48% | 8.47% | -16.19% | -19.72% | -21.63% | -21.08% | -16.37% | -754.98% | -54.18% | -25.1% | -16.18% |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -5.66M | -6.49M | -14.31M | -12.42M | -13.58M | -11.74M | -14.08M | -12.15M | -8.62M | -10.21M | -11.24M | -12.09M | -12.99M | -14.08M | -12.28M | -10.41M | -10.85M | -11.58M | -10.14M | -8.94M |
| Net Interest Income | 1.08M | 999K | 1.07M | 1.21M | 1.39M | 1.76M | 1.8M | 1.76M | 2.01M | 1.96M | 1.83M | 501K | 1.27M | 704.58K | 229.92K | 7.58K | 4.91K | 7.15K | 11.45K | 9.22K |
| Interest Income | 1.08M | 999K | 1.07M | 1.21M | 1.39M | 1.76M | 1.8M | 1.76M | 2.01M | 1.96M | 1.83M | 1.47M | 1.27M | 704.58K | 229.92K | 7.58K | 4.91K | 7.15K | 11.45K | 9.22K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 964K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.12M | 1.02M | 1.22M | 1.32M | 1.48M | 2.59M | 2.39M | 2.08M | 2.76M | 2.44M | 2.29M | 1.13M | 2.37M | 1.2M | 179.8K | 1.11M | 871K | 675.86K | 1.21M | 815.53K |
| Pretax Income | -5.66M | -9.83M | -13.24M | -11.2M | -12.11M | -11.74M | -12.21M | -10.55M | -8.62M | -10.21M | -11.24M | -13.06M | -12.99M | -14.08M | -12.28M | -10.41M | -10.85M | -11.58M | -10.14M | -8.13M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 18K | 0 | 0 | 0 | 0 | -124K | 0 | 0 | 0 | -63.95K | 41K | 50K | -20K | 210.29K | 88.42K | 29.8K | 29.98K | 142.3K | 39K | 26.99K |
| Effective Tax Rate % | -0.32% | 0% | 0% | 0% | 0% | 1.06% | 0% | 0% | 0% | 0.63% | -0.36% | -0.38% | 0.15% | -1.49% | -0.72% | -0.29% | -0.28% | -1.23% | -0.38% | -0.33% |
| Net Income | -5.68M | -9.83M | -13.24M | -11.2M | -12.11M | -11.62M | -12.21M | -10.55M | -8.62M | -10.15M | -11.28M | -13.11M | -12.97M | -14.29M | -12.37M | -10.44M | -10.88M | -11.72M | -10.18M | -8.16M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 53.09% | 15.43% | -8.42% | -6.16% | -40.47% | -14.53% | -8.28% | 19.54% | 33.53% | 29% | 8.79% | -25.57% | -19.2% | -21.95% | -21.49% | -27.99% | -38.54% | -96.44% | -56.94% | -12.69% |
| Net Income (Continuing) | -5.68M | -9.83M | -13.24M | -11.2M | -12.11M | -11.62M | -12.21M | -10.55M | -8.62M | -10.15M | -11.28M | -13.11M | -12.97M | -14.29M | -12.37M | -10.44M | -10.88M | -11.72M | -10.18M | -8.16M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.06 | -0.11 | -0.16 | -0.13 | -0.14 | -0.14 | -0.14 | -0.13 | -0.10 | -0.13 | -0.14 | -0.17 | -0.17 | -0.19 | -0.16 | -0.14 | -0.14 | -0.15 | -0.14 | -0.12 |
| EPS Growth % | 54.43% | 21.43% | -14.29% | 0% | -40% | -7.69% | 0% | 23.53% | 41.18% | 31.58% | 12.5% | -21.43% | -21.43% | -26.67% | -14.29% | -16.67% | -16.67% | -61.64% | -27.27% | 0% |
| EPS (Basic) | -0.06 | -0.11 | -0.16 | -0.13 | -0.14 | -0.14 | -0.14 | -0.13 | -0.10 | -0.13 | -0.14 | -0.17 | -0.17 | -0.19 | -0.16 | -0.14 | -0.14 | -0.15 | -0.14 | -0.12 |
| Diluted Shares Outstanding | 89.03M | 85.89M | 85.38M | 85.07M | 84.81M | 84M | 84.53M | 82.46M | 82.08M | 79.79M | 80.88M | 78.3M | 77.98M | 76.91M | 77.44M | 76.25M | 76M | 76M | 70.59M | 68.59M |
| Basic Shares Outstanding | 89.03M | 85.89M | 85.38M | 85.07M | 84.81M | 84M | 84.53M | 82.46M | 82.08M | 79.79M | 80.88M | 78.3M | 77.98M | 76.91M | 77.44M | 76.25M | 76M | 75.78M | 70.59M | 68.59M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |